Trials / Terminated
TerminatedNCT01604252
An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)
A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 503 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome. The total study duration is anticipated to be a maximum of 8 years, including 3 years for patient recruitment and 5 years follow-up.
Conditions
Timeline
- Start date
- 2012-06-20
- Primary completion
- 2017-04-28
- Completion
- 2017-04-28
- First posted
- 2012-05-23
- Last updated
- 2017-07-28
Locations
81 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT01604252. Inclusion in this directory is not an endorsement.